Protara Therapeutics, Inc.
Income Statement
| Line Item | FY2014 |
|---|---|
| Revenue | $2.9M |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $6.4M |
| SG&A Expense | $4.1M |
| Operating Income | $-7.6M |
| Operating Margin | -257.1% |
| Interest Expense | $857.0K |
| Pretax Income | $-3.3M |
| Income Tax Expense | $-110.0K |
| Net Income | $-3.3M |
| Net Margin | -113.4% |
| EPS (Basic) | $-1.58 |
| EPS (Diluted) | $-1.58 |
| Shares Outstanding (Basic) | 32.9M |
| Shares Outstanding (Diluted) | 32.9M |
| Dividends Per Share | — |